Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 10%
Buy 20%
Hold 70%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is projected to see a significant increase in cash rent, leading to incremental growth in its future FFO and AFFO estimates. Additionally, the company's recent portfolio initiatives, such as re-tenanting and rent resets, are expected to contribute to its cash NOI growth. The company also has a strong acquisition pipeline, which further supports its positive outlook. However, there are risks involved, such as potential difficulties in obtaining capital or delays in the re-leasing of properties. Overall, the company's strong financial performance and strategic initiatives make it a promising investment opportunity with potential for future growth.

Bears say

Sabra Health Care REIT is facing significant challenges in its nursing facilities, assisted living centers, and mental health facilities due to weakened behavioral health fundamentals, leading to a decline in its credit strength and prompting a $200 million mortgage repayment that could result in a dilution of near-term FFO estimates. The company's stock has seen a slight increase in response to management's increased FFO guidance for 2026, but with its current valuations trading above future projections, there is limited potential for upside for investors. Additionally, the company's portfolio containing primarily SNF assets and a high concentration of SHOP assets present potential risks and uncertainties for long-term performance.

SBRA has been analyzed by 10 analysts, with a consensus rating of Hold. 10% of analysts recommend a Strong Buy, 20% recommend Buy, 70% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 10 analysts, SBRA has a Hold consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.90, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.90, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.